drugset / Trial / NCT02826070
EFFORT Further Extension Study
Phase 4
Unknown
130 enrolled
Nanfang Hospital, Southern Medical University
Major Science and Technology Special Project of China Twelfth-Five-Year Project · collabNovartis · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to demonstrate that long-term treatment (up to six years) with telbivudine or telbivudine plus adefovir results in the regression in liver inflammation and fibrosis/cirrhosis.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-10
- Completion
- 2017-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adefovir dipivoxil | Small molecule | 10 mg | Oral |
| Subject | Telbivudine | Small molecule | 600 mg | Oral |